Question 1

What does participating in this study involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis clinical trial (NCT06161376). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the S1P levels be measured and what does it mean for my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis clinical trial (NCT06161376). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects from participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis clinical trial (NCT06161376). Contact the study team or your healthcare provider for specific answers.

Question 4

How will this study help improve understanding of my bladder issues?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis clinical trial (NCT06161376). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my symptoms change during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis clinical trial (NCT06161376). Contact the study team or your healthcare provider for specific answers.

What this study is about